Jasper Ridge Partners’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.84K | Hold |
924
| – | – | ﹤0.01% | 147 |
|
|
2025
Q1 | $7.95K | Hold |
924
| – | – | ﹤0.01% | 147 |
|
|
2024
Q4 | $33K | Hold |
924
| – | – | ﹤0.01% | 143 |
|
|
2024
Q3 | $43.7K | Hold |
924
| – | – | ﹤0.01% | 142 |
|
|
2024
Q2 | $46.4K | Hold |
924
| – | – | ﹤0.01% | 144 |
|
|
2024
Q1 | $103K | Hold |
924
| – | – | ﹤0.01% | 140 |
|
|
2023
Q4 | $53.6K | Hold |
924
| – | – | ﹤0.01% | 141 |
|
|
2023
Q3 | $29.3K | Hold |
924
| – | – | ﹤0.01% | 143 |
|
|
2023
Q2 | $76K | Hold |
924
| – | – | ﹤0.01% | 137 |
|
|
2023
Q1 | $94.9K | Hold |
924
| – | – | ﹤0.01% | 143 |
|
|
2022
Q4 | $135K | Hold |
924
| – | – | 0.01% | 132 |
|
|
2022
Q3 | $156K | Hold |
924
| – | – | 0.01% | 133 |
|
|
2022
Q2 | $107K | Hold |
924
| – | – | 0.01% | 137 |
|
|
2022
Q1 | $92K | Hold |
924
| – | – | ﹤0.01% | 147 |
|
|
2021
Q4 | $144K | Hold |
924
| – | – | 0.01% | 147 |
|
|
2021
Q3 | $218K | Hold |
924
| – | – | 0.01% | 138 |
|
|
2021
Q2 | $314K | Hold |
924
| – | – | 0.02% | 118 |
|
|
2021
Q1 | $374K | Sell |
924
-121
| -12% | -$49K | 0.02% | 105 |
|
|
2020
Q4 | $695K | Buy |
1,045
+581
| +125% | +$386K | 0.03% | 89 |
|
|
2020
Q3 | $216K | Buy |
+464
| New | +$216K | 0.01% | 107 |
|